Company profile

Vertero Therapeutics, Inc.

Pioneering science beyond the brain to treat neurodegenerative diseases at their source

Industry
Biotechnology Research
Employees
12
Headquarters
Woburn, Massachusetts
Founded
2016
LinkedIn followers
4,206
Office locations
1

Vertero Therapeutics, Inc. company summary

Vertero Therapeutics, Inc. is a company in the Biotechnology Research industry, headquartered in Woburn, Massachusetts, founded in 2016. On LinkedIn the company has around 12 employees and 4,206 followers. Its listed specialties include Neurological disorders and diseases, parkinson's disease, gut-brain axis, small molecule, Neurodegenerative diseases.

What technology does Vertero Therapeutics, Inc. use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Vertero Therapeutics, Inc.

Vertero Therapeutics is pioneering science beyond the brain to treat neurodegenerative diseases at their source. Vertero’s development pipeline of differentiated therapies targets the peripheral nervous system to delay onset and slow progression of challenging conditions such as Parkinson’s disease. The company's lead program, VT-5006, is designed to precisely treat a validated target in the gut that feeds the protein aggregation and inflammation implicated in Parkinson’s disease. Vertero is preparing to initiate a Phase 1 clinical trial of VT-5006. The company also has an asset targeting bile acid dysregulation in early development for undisclosed indications.

Specialties

Neurological disorders and diseasesparkinson's diseasegut-brain axissmall moleculeNeurodegenerative diseases

Where is Vertero Therapeutics, Inc. located?

Vertero Therapeutics, Inc. lists 1 location.

Woburn, Massachusetts, USHQ
400 Tradecenter Dr

Compare companies similar to Vertero Therapeutics, Inc.

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Vertero Therapeutics, Inc.
vertero.com
Biotechnology Research122016Woburn, Massachusetts
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Vertero Therapeutics, Inc.

What does Vertero Therapeutics, Inc. do?

Vertero Therapeutics is pioneering science beyond the brain to treat neurodegenerative diseases at their source. Vertero’s development pipeline of differentiated therapies targets the peripheral nervous system to delay onset and slow progression of challenging conditions such as Parkinson’s disease. The company's lead program, VT-5006, is designed to precisely treat a validated target in the gut that feeds the protein aggregation and inflammation implicated in Parkinson’s disease. Vertero is preparing to initiate a Phase 1 clinical trial of VT-5006. The company also has an asset targeting bile acid dysregulation in early development for undisclosed indications.

How many employees does Vertero Therapeutics, Inc. have?

Vertero Therapeutics, Inc. has around 12 employees on LinkedIn.

Where is Vertero Therapeutics, Inc. headquartered?

Vertero Therapeutics, Inc. is headquartered in Woburn, Massachusetts.

When was Vertero Therapeutics, Inc. founded?

Vertero Therapeutics, Inc. was founded in 2016.

Build a lead list from companies like Vertero Therapeutics, Inc.

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.